Quality assessment of the guidelines for the management of malignant pleural effusions and ascites

World J Surg Oncol. 2020 Dec 11;18(1):331. doi: 10.1186/s12957-020-02097-y.

Abstract

Objectives: To fully assess the quality of the guidelines for the management of malignant pleural effusions (MPE) and ascites and reveal the heterogeneity of recommendations and possible reasons among guidelines.

Methods: A systematic search was performed in the database to obtain guidelines for the management of MPE and ascites. The AGREE IIGtool was used to assess the quality of these guidelines. The Measurement Scale of Rate of Agreement (MSRA) was introduced to assess the scientific agreement of formulated recommendations for the management of MPE and ascites among guidelines, and evidence supporting these recommendations was extracted and analyzed.

Results: Nine guidelines were identified. Only 4 guidelines scored more than 60% and are worth recommending. Recommendations were also heterogeneous among guidelines for the management of MPE, and the main reasons were the different emphases of the recommendations for the treatment of MPE, the contradictions in recommendations, and the unreasonably cited evidence for MPE.

Conclusions: The quality of the management guidelines for patients with MPE and malignant ascites was highly variable. Specific improvement of the factors leading to the heterogeneity of recommendations will be a reasonable and effective way for developers to upgrade the recommendations in the guidelines for MPE.

Keywords: Guideline appraisal; Malignant ascites; Malignant pleural effusion.

Publication types

  • Review

MeSH terms

  • Ascites / etiology
  • Ascites / therapy
  • Humans
  • Pleural Effusion, Malignant* / diagnosis
  • Pleural Effusion, Malignant* / therapy
  • Prognosis